Cargando…
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
PURPOSE: A multidisciplinary expert panel convened to formulate state-of-the-art recommendations for optimisation of selective internal radiation therapy (SIRT) with yttrium-90 ((90)Y)-resin microspheres. METHODS: A steering committee of 23 international experts representing all participating specia...
Autores principales: | Levillain, Hugo, Bagni, Oreste, Deroose, Christophe M., Dieudonné, Arnaud, Gnesin, Silvano, Grosser, Oliver S., Kappadath, S. Cheenu, Kennedy, Andrew, Kokabi, Nima, Liu, David M., Madoff, David C., Mahvash, Armeen, Martinez de la Cuesta, Antonio, Ng, David C. E., Paprottka, Philipp M., Pettinato, Cinzia, Rodríguez-Fraile, Macarena, Salem, Riad, Sangro, Bruno, Strigari, Lidia, Sze, Daniel Y., de Wit van der veen, Berlinda J., Flamen, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113219/ https://www.ncbi.nlm.nih.gov/pubmed/33433699 http://dx.doi.org/10.1007/s00259-020-05163-5 |
Ejemplares similares
-
Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy
por: Mikell, Justin K, et al.
Publicado: (2015) -
Blood flow diversion using the microvascular plug to avoid non target delivery of radioactive microspheres
por: Abdelsalam, Mohamed E., et al.
Publicado: (2020) -
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021) -
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020) -
A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of (90)Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study
por: Mahvash, Armeen, et al.
Publicado: (2022)